Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Journal of Medicinal Chemistry
|
January 15, 2008
Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy
Deborah H Slee, Xiaohu Zhang, Manisha Moorjani, et al.
JNCI Cancer Spectrum
|
June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
Neil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.
Anesthesiology
|
November 10, 2025
Paravertebral or serratus anterior plane block combined with PECS I (interpectoral) blocks versus paravertebral block for mastectomy: A cluster-randomized trial of 1507 patients
Hanae K Tokita, Melissa J Assel, Joanna Serafin, et al.
Journal of Medicinal Chemistry
|
October 25, 2008
Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease
Xiaohu Zhang, John E Tellew, Zhiyong Luo, et al.
Journal of Medicinal Chemistry
|
March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents
Deborah H Slee, Yongsheng Chen, Xiaohu Zhang, et al.
Journal of Medicinal Chemistry
|
January 15, 2009
N-[6-amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2A receptor antagonists with improved drug like properties and in vivo efficacy
Marion C Lanier, Manisha Moorjani, Zhiyong Luo, et al.
Journal of Medicinal Chemistry
|
March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationships
Deborah H Slee, Manisha Moorjani, Xiaohu Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial
Tanios S Bekaii-Saab, Davide Melisi, Hanneke Wilmink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2026
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional Study
Cameron Crowell, Nikhil P Mankuzhy, Julie Bennett, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Journal of Medicinal Chemistry
|
January 15, 2008
Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy
Deborah H Slee, Xiaohu Zhang, Manisha Moorjani, et al.
JNCI Cancer Spectrum
|
June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
Neil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.
Anesthesiology
|
November 10, 2025
Paravertebral or serratus anterior plane block combined with PECS I (interpectoral) blocks versus paravertebral block for mastectomy: A cluster-randomized trial of 1507 patients
Hanae K Tokita, Melissa J Assel, Joanna Serafin, et al.
Journal of Medicinal Chemistry
|
October 25, 2008
Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease
Xiaohu Zhang, John E Tellew, Zhiyong Luo, et al.
Journal of Medicinal Chemistry
|
March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents
Deborah H Slee, Yongsheng Chen, Xiaohu Zhang, et al.
Journal of Medicinal Chemistry
|
January 15, 2009
N-[6-amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2A receptor antagonists with improved drug like properties and in vivo efficacy
Marion C Lanier, Manisha Moorjani, Zhiyong Luo, et al.
Journal of Medicinal Chemistry
|
March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationships
Deborah H Slee, Manisha Moorjani, Xiaohu Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial
Tanios S Bekaii-Saab, Davide Melisi, Hanneke Wilmink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2026
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional Study
Cameron Crowell, Nikhil P Mankuzhy, Julie Bennett, et al.
Page
of 10